Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > A move all Oncy shareholders need to make, to screw the shor

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Apr 29, 2024 1:40pm

141 Views

Post# 36013040

RE:RE:RE:A move all Oncy shareholders need to make, to screw the shor

CMHthats correct for the TSX, but for the Nasdaq its a bit more hassle.by the way, definitely do NOT put your shares up for sale at $6!..If they announce a multi billion dollar buyout, the price will soar FAR above $6, and you will miss out big time!..maybe try $600.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season